Jubilant Pharmova Q3FY21 consolidated PAT at Rs. 309.93 Cr
News

Jubilant Pharmova Q3FY21 consolidated PAT at Rs. 309.93 Cr

The company posted net profit of Rs.203.38 crores for the period ended December 31, 2019.

  • By IPP Bureau | February 08, 2021

Jubilant Pharmova Limited has reported total income of Rs.1774.93 crores during the period ended December 31, 2020 as compared to Rs.1594.80 crores during the period ended September 30, 2020.

 

The company reported total income of Rs.1521.20 crores during the period ended December 31, 2019.

 

Jubilant Pharmova has posted net profit of Rs.309.93 crores for the period ended December 31, 2020 as against net profit of Rs.224.03 crores for the period ended September 30, 2020.

 

The company posted net profit of Rs.203.38 crores for the period ended December 31, 2019.

 

For the 9 months period ended December 31, 2020, Jubilant Pharmova has reported total income of Rs.4529.71 crores during the 9 months period ended December 31, 2020 as compared to Rs.4427.36 crores during the 9 months period ended December 31, 2019.

 

The company has posted net profit of Rs.621.97 crores for the 9 months period ended December 31, 2020 as against net profit of Rs.637.75 crores for the 9 months period ended December 31, 2019.

 

The company has reported EPS of Rs.39.05 for the 9 months period ended December 31, 2020 as compared to Rs.40.04 for the 9 months period ended December 31, 2019.

Upcoming E-conference

Other Related stories

Startup

Digitization